Chidamide in the treatment of peripheral T-cell lymphoma

References

• VoseJArmitageJWeisenburgerDInternational T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomesJ Clin Oncol200826254124413018626005
   PubMed Web of Science ®Google Scholar
• AuWYMaSYChimCSClinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 yearsAnn Oncol200516220621415668271
   PubMed Web of Science ®Google Scholar
• WeisenburgerDDSavageKJHarrisNLInternational Peripheral T-Cell Lymphoma Project. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell lymphoma projectBlood2011117123402340821270441
   PubMed Web of Science ®Google Scholar
• SimonAPeochMCasassusPUpfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95Br J Haematol2010151215916620738307
   PubMed Web of Science ®Google Scholar
• SchmitzNTrümperLZiepertMTreatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study GroupBlood2010116183418342520660290
   PubMed Web of Science ®Google Scholar
• AbramsonJSFeldmanTKroll-DesrosiersARPeripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapyAnn Oncol201425112211221725193992
   PubMed Web of Science ®Google Scholar
• ReimerPRüdigerTGeissingerEAutologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter studyJ Clin Oncol200927110611319029417
   PubMed Web of Science ®Google Scholar
• d’AmoreFRelanderTLauritzsenGFUp-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01J Clin Oncol201230253093309922851556
   PubMed Web of Science ®Google Scholar
• ChanTSKwongYLTseENovel therapeutic agents for T-cell lymphomasDiscov Med20131686273523911229
   PubMedGoogle Scholar
• HollidayRThe inheritance of epigenetic defectsScience198723848241631703310230
   PubMed Web of Science ®Google Scholar
• EstellerMEpigenetics in cancerN Engl J Med2008358111148115918337604
   PubMed Web of Science ®Google Scholar
• GregerVPassargeEHoppingWMessmerEHorsthemkeBEpigenetic changes may contribute to the formation and spontaneous regression of retinoblastomaHum Genet19898321551582550354
   PubMed Web of Science ®Google Scholar
• MerloAHermanJGMaoL5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancersNat Med1995176866927585152
   PubMed Web of Science ®Google Scholar
• EstellerMSilvaJMDominguezGPromoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumorsJ Natl Cancer Inst200092756456910749912
   PubMedGoogle Scholar
• HaberlandMMontgomeryRLOlsonENThe many roles of histone deacetylases in development and physiology: implications for disease and therapyNat Rev Genet2009101324219065135
   PubMed Web of Science ®Google Scholar
• ParisMPorcelloniMBinaschiMFattoriDHistone deacetylase inhibitors: from bench to clinicJ Med Chem20085161505152918247554
   PubMed Web of Science ®Google Scholar
• NingZQLiZBNewmanMJChidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicityCancer Chemother Pharmacol201269490190922080169
   PubMed Web of Science ®Google Scholar
• LiuLChenBQinSA novel histone deacetylase inhibitor chidamide induces apoptosis of human colon cancer cellsBiochem Biophys Res Commun2010392219019520060381
   PubMedGoogle Scholar
• GongKXieJYiHLiWCS055 (Chidamide/HBI-8000), a novel histone deacetylase inhibitor, induces G1 arrest, ROS-dependent apoptosis and differentiation in human leukaemia cellsBiochem J2012443373574622339555
   PubMed Web of Science ®Google Scholar
• WangHGuoYFuMAntitumor activity of chidamide in hepatocellular carcinoma cell linesMol Med Rep2012561503150822484326
   PubMed Web of Science ®Google Scholar
• ZhaoBHeTChidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancerOncol Rep201533130431025384499
   PubMedGoogle Scholar
• QiaoZRenSLiWChidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cellsBiochem Biophys Res Commun201343419510123541946
   PubMedGoogle Scholar
• ZhouYPanDSShanSNon-toxic dose chidamide synergistically enhances platinum-induced DNA damage responses and apoptosis in non-small-cell lung cancer cellsBiomed Pharmacother201468448349124721323
   PubMed Web of Science ®Google Scholar
• LiuLQiuSLiuYChidamide and 5-flurouracil show a synergistic antitumor effect on human colon cancer xenografts in nude miceNeoplasma201663219320026774139
   PubMed Web of Science ®Google Scholar
• YaoYZhouJWangLIncreased PRAME-specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabinePLoS One201388e7052223940586
   PubMed Web of Science ®Google Scholar
• DongMNingZQXingPYPhase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomasCancer Chemother Pharmacol20126961413142222362161
   PubMed Web of Science ®Google Scholar
• ShiYDongMHongXResults from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphomaAnn Oncol20152681766177126105599
   PubMed Web of Science ®Google Scholar
• CoiffierBProBPrinceHMResults from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapyJ Clin Oncol201230663163622271479
   PubMed Web of Science ®Google Scholar
• O’ConnorOAHorwitzSMassziTBelinostat in patients with relapsed or refractory peripheral T-cell lymphoma: results of the pivotal phase II BELIEF (CLN-19) studyJ Clin Oncol201533232492249926101246
   PubMed Web of Science ®Google Scholar
• KimSJKimJHKiCSKoYHKimJSKimWSEpstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsinAnn Oncol201627350851326658891
   PubMed Web of Science ®Google Scholar